510(k) Report

510(k) · Cleared

Cleared

Cytotech Rubella Igg Enzyme Immunoassay

K864315510(k) TraditionalCleared Feb 2, 198791-day reviewClass II21 CFR 866.3510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cytotech, Inc. · LFX Enzyme Linked Immunoabsorbent Assay, Rubella

Cleared on Feb 2, 1987 after a 91-day review. FDA has not posted a summary or statement for it, so its predicates are not known.

Decided
Feb 2, 1987
Review
91 days
Class
Class II
Product code
LFX
Recalls
None
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K864315Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LFX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LFX device

  1. #1 K250588 Access Rubella IgGscore 10.4 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LFX devices

LFX Enzyme Linked Immunoabsorbent Assay, Rubella: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LFX

2in 2025

2007: 12008: 32010: 22011: 12012: 12025: 2
2007high 3 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LFX

354in 2008

2008: 354 days median
2007high 354 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LFX

1in 2021

2007: 22008: 22009: 32010: 22011: 12016: 22021: 1
2007high 3 (2009) · low 0 (2012)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LFX

12in 2025

2007: 52008: 3672009: 192010: 182011: 892012: 372013: 152014: 132015: 152016: 472017: 102018: 242019: 162020: 212021: 132022: 132023: 72024: 132025: 12
2007high 367 (2008) · low 5 (2007)2025

MAUDE reports naming product code LFX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—25
200833542367
20090—319
20102—218
20111—189
20121—037
20130—015
20140—013
20150—015
20160—247
20170—010
20180—024
20190—016
20200—021
20210—113
20220—013
20230—07
20240—013
20252—012
20260—0—
Cite this page

510(k) Report. “K864315: Cytotech Rubella Igg Enzyme Immunoassay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K864315

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026